James B Breitmeyer - Net Worth and Insider Trading
James B Breitmeyer Net Worth
The estimated net worth of James B Breitmeyer is at least $367,050 dollars as of 2024-05-03. James B Breitmeyer is the CEO of Oncternal Therapeutics Inc and owns about 38,159 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $333,700. James B Breitmeyer is also the Director of Zogenix Inc and owns about 1,250 shares of Zogenix Inc (ZGNX) stock worth over $33,350. Details can be seen in James B Breitmeyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James B Breitmeyer has not made any transactions after 2023-04-14 and currently still holds the listed stock(s).
Transaction Summary of James B Breitmeyer
James B Breitmeyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James B Breitmeyer owns 3 companies in total, including Otonomy Inc (OTIC) , Zogenix Inc (ZGNX) , and Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of James B Breitmeyer’s form 4 insider trades.
Insider Ownership Summary of James B Breitmeyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTIC | Otonomy Inc | 2018-06-19 | director |
| ZGNX | Zogenix Inc | 2020-05-29 | director |
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | director & President & CEO |
James B Breitmeyer Latest Holdings Summary
James B Breitmeyer currently owns a total of 2 stocks. Among these stocks, James B Breitmeyer owns 38,159 shares of Oncternal Therapeutics Inc (ONCT) as of April 14, 2023, with a value of $333,700 and a weighting of 90.91%. James B Breitmeyer also owns 1,250 shares of Zogenix Inc (ZGNX) as of December 16, 2019, with a value of $33,350 and a weighting of 9.09%.
Latest Holdings of James B Breitmeyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2023-04-14 | 38,159 | 8.75 | 333,700 |
| ZGNX | Zogenix Inc | 2019-12-16 | 1,250 | 26.68 | 33,350 |
Holding Weightings of James B Breitmeyer
James B Breitmeyer Form 4 Trading Tracker
According to the SEC Form 4 filings, James B Breitmeyer has made a total of 2 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 7,500 shares on April 14, 2023, which cost James B Breitmeyer around $43,500.
According to the SEC Form 4 filings, James B Breitmeyer has made a total of 2 transactions in Zogenix Inc (ZGNX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Zogenix Inc is the sale of 5,000 shares on December 16, 2019, which brought James B Breitmeyer around $250,000.
Insider Trading History of James B Breitmeyer
- 1
James B Breitmeyer Trading Performance
GuruFocus tracks the stock performance after each of James B Breitmeyer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James B Breitmeyer is -0.27%. GuruFocus also compares James B Breitmeyer's trading performance to market benchmark return within the same time period. The performance of stocks bought by James B Breitmeyer within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James B Breitmeyer's insider trading performs compared to the benchmark.
Performance of James B Breitmeyer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.18 | | | | | |
| Relative Return to S&P 500(%) | 0.68 | | | | | |
James B Breitmeyer Ownership Network
James B Breitmeyer Owned Company Details
What does Otonomy Inc do?
Who are the key executives at Otonomy Inc?
James B Breitmeyer is the director of Otonomy Inc. Other key executives at Otonomy Inc include Chief Scientific Officer Alan Charles Foster , director & President & CEO David Allen Weber , and CFO/Ch. Business Offcr & Sec. Paul E Cayer .
Otonomy Inc (OTIC) Insider Trades Summary
Over the past 18 months, James B Breitmeyer made no insider transaction in Otonomy Inc (OTIC). Other recent insider transactions involving Otonomy Inc (OTIC) include a net sale of 42,242 shares made by Vickie L Capps ,
In summary, during the past 3 months, insiders sold 0 shares of Otonomy Inc (OTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,242 shares of Otonomy Inc (OTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,242 shares.
Otonomy Inc (OTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Otonomy Inc Insider Transactions
James B Breitmeyer Mailing Address
Above is the net worth, insider trading, and ownership report for James B Breitmeyer. Currently GuruFocus does not have mailing address information for James B Breitmeyer.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
